Tech Giants and Biotech Breakthroughs

This chapter explores major tech companies' missed acquisition opportunities and their potential impacts, alongside reflections on historical precedents. The discussion then highlights Insmed's recent stock surge due to positive trial results, setting the stage for an interview with its CEO about the company's future.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app